𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia

✍ Scribed by L. Joseph Melton III; Cynthia L. Leibson; Sara J. Achenbach; James H. Bower; Demetrius M. Maraganore; Ann L. Oberg; Walter A. Rocca


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
75 KB
Volume
21
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In an inception cohort of 196 Olmsted County, Minnesota, residents with Parkinson's disease (PD) first recognized in 1976 to 1995, we tested whether the increased risk of bone fractures is associated with concomitant dementia. Using the data resources of the Rochester Epidemiology Project, information about PD, dementia, other clinical risk factors for fracture and fracture events was obtained from review of complete inpatient and outpatient medical records spanning each subject's residence in the community. Compared to an equal number of age‐ and sex‐matched non‐PD referent subjects from the community, PD patients were at a 2.2‐fold increased risk of fractures generally and a 3.2‐fold greater risk of hip fractures specifically. Adjusting for age, the independent predictors of overall fracture risk in the PD subjects included female sex (hazard ratio [HR] 1.6; 95% confidence interval [CI], 1.1–2.3), dementia (HR, 1.6; 95% CI, 1.1–2.4) and chronic depression, which was associated with a reduced risk (HR, 0.4; 95% CI, 0.2–0.8). Hip fractures were predicted by dementia (HR, 2.2; 95% CI, 1.2–4.1). The increased fracture risk in patients with PD is not entirely explained by concomitant dementia, and additional study is needed to determine the relative contributions to fracture risk of falls versus bone loss in these patients. Β© 2006 Movement Disorder Society


πŸ“œ SIMILAR VOLUMES


Risk of cancer after the diagnosis of Pa
✍ Alexis Elbaz; Brett J. Peterson; James H. Bower; Ping Yang; Demetrius M. Maragan πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

## Abstract We investigated the risk of cancer after the diagnosis of Parkinson's disease (PD) through a historical cohort study. We used the medical records‐linkage system of the Rochester Epidemiology Project to identify all incident cases of PD in Olmsted County, Minnesota from 1976 through 1995

Associations between family history of P
✍ Martin Wilhelm Kurz; Jan Petter Larsen; Jan Terje Kvaloy; Dag Aarsland πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 81 KB πŸ‘ 1 views

## Abstract Dementia is common in patients with Parkinson's disease (PDD). The etiology of PDD is still unclear, but exciting advances have been made in discovering pathogenetic components in Parkinson's disease (PD), implicating the role of genetic factors. It is, however, still controversial whet

Racial differences in the diagnosis of P
✍ Nabila Dahodwala; Andrew Siderowf; Ming Xie; Elizabeth Noll; Matthew Stern; Davi πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 1 views

## Abstract The objective of this cohort study was to determine the incidence of Parkinson's disease (PD) and the effects of race/ethnicity, other demographic characteristics, geography, and healthcare utilization on probability of diagnosis. The authors used the Pennsylvania state Medicaid claims

Long-term cognitive profile and incidenc
✍ Selma Aybek; Aline Gronchi-Perrin; Alexandre Berney; Sabina Catalano ChiuvΓ©; Jea πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 140 KB

## Abstract An effect of subthalamic nucleus deep brain stimulation (STN‐DBS) on cognition has been suspected but long‐term observations are lacking. The aim of this study was to evaluate the long‐term cognitive profile and the incidence of dementia in a cohort of Parkinson's disease (PD) patients

Association between amantadine and the o
✍ Rivka Inzelberg; Ubaldo Bonuccelli; Edna Schechtman; Ala Miniowich; Rosa Strugat πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 64 KB πŸ‘ 1 views

## Abstract The objective of this study is to compare the occurrence of dementia among Parkinson's disease (PD) patients treated with amantadine (AM group) with those never exposed to it (NoAM group). PD dementia shares neuroanatomical and biochemical similarities with Alzheimer's disease (AD). Mem